Alaunos Therapeutics, Inc.

TCRT

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001107421

SEC filings (opens in a new tab)

No open-market purchases or sales by Alaunos Therapeutics, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $204.4K in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Alaunos Therapeutics, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021 All holders in Q1 2021

13F holders of TCRT: Q1 2021 compared with Q2 2021
Measure	Q1 2021	Of which not filed for Q2 2021	Q2 2021	Change
Holders	153	2	156	+5
Shares	117.4M	32.4K	112.7M	−4.67M (−4.0%)
Value	$422.7M	$117.0K	$297.6M	−$125.0M (−29.6%)

2 institutions that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (24)

Institutions that held Alaunos Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to TCRT in Q2 2021
Institution	Shares	Value	% of portfolio
Mirae Asset Global Investments Co., Ltd.	472,895	$1.25M	0.00%
Millennium Management LLC	369,162	$975.0K	0.00%
Citadel Advisors LLC	245,673	$649.0K	0.00%
HRT Financial LP	241,922	$638.0K	0.01%
Magnolia Capital Advisors LLC	97,889	$258.0K	0.11%
ExodusPoint Capital Management, LP	68,881	$182.0K	0.00%
AXA S.A.	60,300	$159.0K	0.00%
Tudor Investment Corp Et Al	52,097	$138.0K	0.00%
Qube Research & Technologies Ltd	48,099	$127.0K	0.00%
Ergoteles LLC	45,800	$121.0K	0.00%
Lincoln National Corp	37,500	$99.0K	0.00%
Susquehanna Fundamental Investments, LLC	21,925	$58.0K	0.00%
Glenmede Trust Co NA	20,000	$52.0K	0.00%
Jump Financial, LLC	17,300	$46.0K	0.00%
Alpine Global Management, LLC	16,430	$43.0K	0.01%
HSBC Holdings PLC	12,888	$35.0K	0.00%
Equitec Proprietary Markets, LLC	12,028	$32.0K	0.02%
Xponance, Inc.	11,036	$29.0K	0.00%
Centiva Capital, LP	10,262	$27.0K	0.00%
Point72 Hong Kong Ltd	3,103	$8.00K	0.00%
Asset Dedication, LLC	1,266	$3.00K	0.00%
Cutler Group LP	1,000	$2.00K	0.00%
Berman Capital Advisors, LLC	424	$1.00K	0.00%
Advisory Services Network, LLC	162	$0	0.00%

Sold out (19)

Institutions that held Alaunos Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of TCRT in Q2 2021
Institution	Shares, Q1 2021	Value, Q1 2021
California Public Employees Retirement System	433,400	$1.56M
Alps Advisors Inc	388,379	$1.40M
Migdal Insurance & Financial Holdings Ltd.	246,595	$888.0K
Russell Investments Group, Ltd.	78,581	$282.0K
Virtu Financial LLC	69,999	$252.0K
SFMG, LLC	62,433	$225.0K
Quantbot Technologies LP	49,300	$177.0K
Quantitative Investment Management, LLC	22,874	$82.0K
Chevy Chase Trust Holdings, Inc.	16,737	$60.0K
PDT Partners, LLC	13,600	$49.0K
Pacer Advisors, Inc.	12,615	$45.0K
Y-Intercept (Hong Kong) Ltd	12,541	$42.0K
Scotia Capital Inc.	10,300	$37.0K
Bank of Montreal	7,983	$27.0K
International Assets Investment Management, LLC	5,292	$17.0K
NEXT Financial Group, Inc	1,000	$4.00K
IFP Advisors, Inc	1,000	$4.00K
MPS Loria Financial Planners, LLC	516	$1.00K
Fifth Third Bancorp	8	$0

Not filed for Q2 2021 yet (2)

Institutions that held Alaunos Therapeutics, Inc. at the end of Q1 2021 and haven't filed a 13F for Q2 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding TCRT in Q1 2021 that haven't filed for Q2 2021
Institution	Shares, Q1 2021	Value, Q1 2021
E Fund Management Co., Ltd.	22,426	$81.0K
Bokf, NA	10,000	$36.0K